Pages that link to "Q44089003"
Jump to navigation
Jump to search
The following pages link to Laparoscopic adjustable gastric banding for the treatment of morbid (grade 3) obesity and its metabolic complications: a three-year study. (Q44089003):
Displaying 50 items.
- New obesity classification criteria as a tool for bariatric surgery indication (Q26774656) (← links)
- Reductions in cardiovascular risk after bariatric surgery (Q26830659) (← links)
- Surgical treatment of type 2 diabetes: the surgeon perspective. (Q30405974) (← links)
- Do Incretins play a role in the remission of type 2 diabetes after gastric bypass surgery: What are the evidence? (Q33789529) (← links)
- Effects of weight loss in metabolically healthy obese subjects after laparoscopic adjustable gastric banding and hypocaloric diet (Q33847375) (← links)
- Superior appetite hormone profile after equivalent weight loss by gastric bypass compared to gastric banding (Q33879265) (← links)
- Sex differences in visceral adipose tissue post-bariatric surgery compared to matched non-surgical controls. (Q33941668) (← links)
- Retinol-binding protein 4, visceral fat, and the metabolic syndrome: effects of weight loss (Q34013478) (← links)
- Improvement in ß-cell function in patients with normal and hyperglycemia following Roux-en-Y gastric bypass surgery. (Q34305172) (← links)
- Long-term effect of bariatric surgery on liver enzymes in the Swedish Obese Subjects (SOS) study. (Q34653992) (← links)
- Current management strategies for coexisting diabetes mellitus and obesity (Q35147057) (← links)
- Resolution of diabetes mellitus by ileal transposition compared with biliopancreatic diversion in a nonobese animal model of type 2 diabetes (Q35327470) (← links)
- Biliary pancreatic diversion and laparoscopic adjustable gastric banding in morbid obesity: their long-term effects on metabolic syndrome and on cardiovascular parameters (Q35574815) (← links)
- Obesity, bariatric surgery and type 2 diabetes--a systematic review (Q35896348) (← links)
- Advances in diabetes for the millennium: nutritional therapy of type 2 diabetes (Q36007869) (← links)
- The effect of gastric banding on kidney stone disease (Q36021546) (← links)
- Systematic review of long-term weight loss studies in obese adults: clinical significance and applicability to clinical practice (Q36183802) (← links)
- Long-term mortality and incidence of cardiovascular diseases and type 2 diabetes in diabetic and nondiabetic obese patients undergoing gastric banding: a controlled study (Q36625446) (← links)
- Reduction in weight and BMI and changes in Co-morbidities following laparoscopic adjustable gastric banding procedure for morbidly obese patients in Bahrain: a five year longitudinal study (Q36636889) (← links)
- Metabolic changes one year after laparoscopic adjustable gastric banding operation in morbidly obese subjects (Q36768072) (← links)
- Weight loss at first postoperative visit predicts long-term outcome of Roux-en-Y gastric bypass using Duke weight loss surgery chart (Q36786714) (← links)
- Cholesterol metabolism after bariatric surgery in grade 3 obesity: differences between malabsorptive and restrictive procedures (Q36868079) (← links)
- Methylation and expression of immune and inflammatory genes in the offspring of bariatric bypass surgery patients (Q36956113) (← links)
- Impact of weight-loss surgery and diabetes status on serum ALT levels (Q37039813) (← links)
- Effects of alternate fasting or very low calorie diet and low calorie diet on metabolic syndrome in severely obese patients (Q37083013) (← links)
- Impact of different bariatric surgical procedures on insulin action and beta-cell function in type 2 diabetes (Q37105254) (← links)
- Cardiovascular risk after bariatric surgery for obesity (Q37274649) (← links)
- Nonalcoholic fatty liver disease and the coronary artery disease (Q37750546) (← links)
- Advances in the Etiology and Management of Hyperinsulinemic Hypoglycemia After Roux-en-Y Gastric Bypass (Q37889178) (← links)
- Preoperative Predictors of Weight Loss Following Bariatric Surgery: Systematic Review (Q37915396) (← links)
- Increased levels of the Akt-specific phosphatase PH domain leucine-rich repeat protein phosphatase (PHLPP)-1 in obese participants are associated with insulin resistance. (Q39565163) (← links)
- Bariatric surgery as urate-lowering therapy in severe obesity (Q42657040) (← links)
- The effect of restrictive bariatric surgery on urinary stone risk factors (Q43104468) (← links)
- Early effects of gastric banding (LGB) and of biliopancreatic diversion (BPD) on insulin sensitivity and on glucose and insulin response after OGTT. (Q43179099) (← links)
- Weight loss through gastric banding: effects on TSH and thyroid hormones in obese subjects with normal thyroid function (Q43260385) (← links)
- Sleeve gastrectomy provides a better control of diabetes by decreasing ghrelin in the diabetic Goto-Kakizaki rats (Q43281547) (← links)
- Amelioration of glycemic control by sleeve gastrectomy and gastric bypass in a lean animal model of type 2 diabetes: restoration of gut hormone profile (Q43499924) (← links)
- Impact of bariatric surgery on serum urate targets in people with morbid obesity and diabetes: a prospective longitudinal study (Q43991225) (← links)
- Effect of Laparoscopic Roux-En Y Gastric Bypass on Type 2 Diabetes Mellitus (Q44609117) (← links)
- Visceral obesity is a negative predictor of remission of diabetes 1 year after bariatric surgery (Q44716465) (← links)
- Medium-term outcomes of patients with insulin-dependent diabetes after laparoscopic adjustable gastric banding (Q45367142) (← links)
- Morbid obesity and inflammation: a prospective study after adjustable gastric banding surgery. (Q46013144) (← links)
- Metabolic outcomes of obese diabetic patients following laparoscopic adjustable gastric banding. (Q46014659) (← links)
- Elevated concentrations of liver enzymes and ferritin identify a new phenotype of insulin resistance: effect of weight loss after gastric banding (Q46343950) (← links)
- In morbid obesity, metabolic abnormalities and adhesion molecules correlate with visceral fat, not with subcutaneous fat: effect of weight loss through surgery (Q46482208) (← links)
- Raised CRP levels in obese patients: symptoms of depression have an independent positive association. (Q46580893) (← links)
- Effect of weight reduction following bariatric surgery on serum visfatin and adiponectin levels in morbidly obese subjects (Q47165590) (← links)
- Liver steatosis (LS) evaluated through chemical-shift magnetic resonance imaging liver enzymes in morbid obesity; effect of weight loss obtained with intragastric balloon gastric banding. (Q47207424) (← links)
- Gastrointestinal surgery for obesity and diabetes: weight loss and control of hyperglycemia. (Q47279738) (← links)
- Increase in visfatin after weight loss induced by gastroplastic surgery (Q47312067) (← links)